Integrated Analysis Reveals That Long Non-Coding RNA TUBA4B Can Be Used as a Prognostic Biomarker in Various Cancers | Zendy

Ting Zhang | Zendy; Dongming Wu | Zendy; Shihua Deng | Zendy; Rong Han | Zendy; Teng Liu | Zendy; Jing Li | Zendy; Ying Xu | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Integrated Analysis Reveals That Long Non-Coding RNA TUBA4B Can Be Used as a Prognostic Biomarker in Various Cancers

Author(s) -

Ting Zhang,

Dongming Wu,

Shihua Deng,

Rong Han,

Teng Liu,

Jing Li,

Ying Xu

Publication year - 2018

Publication title -

cellular physiology and biochemistry

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.486

H-Index - 87

eISSN - 1421-9778

pISSN - 1015-8987

DOI - 10.1159/000492991

Subject(s) - hazard ratio , medicine , oncology , biomarker , confidence interval , lung cancer , breast cancer , colorectal cancer , meta analysis , ovarian cancer , cancer , long non coding rna , gene , rna , biology , biochemistry

Recent studies have reported the importance of tubulin alpha 4b (TUBA4B), a long non-coding RNA, in the development of several cancers; however, studies on its clinical significance are rare. In the present meta-analysis, we investigated whether TUBA4B can be used as a prognostic biomarker in human cancers.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research